Lululemon delivered FY2025 revenue of $11.1B, up 5% year-over-year, but the headline growth masks a deteriorating profitability profile. Gross margin contracted 260 basis points to 56.6% and operating margin fell from 23.7% to 19.9%, driven by tariff-related cost increases (estimated at $240M in FY2025, rising to $320M in FY2026), elevated markdowns in the Americas, and SG&A deleverage. Q4 EPS of $5.01 beat consensus of $4.77, but FY2026 EPS guidance of $12.10–$12.30 represents a ~7% decline from FY2025’s $13.26 — a rare earnings retreat for this former high-flier.
The geographic divergence is stark. Americas comparable sales declined 5% as the brand faces intensifying competition from Alo Yoga, Vuori, and On Running, particularly with younger and affluent consumers. In contrast, international revenue surged 33%, led by China Mainland comps of +24%, and the company is entering six new markets in 2026 through franchise partnerships, including India via Tata CLiQ. The question is whether international strength can offset persistent North American softness long enough for a turnaround.
The investment thesis hinges on multiple catalysts in flux. Incoming CEO Heidi O’Neill (effective September 2026) brings 30+ years at Nike and could reinvigorate brand strategy, but the transition creates near-term execution risk. Founder Chip Wilson’s proxy fight — alongside activist Elliott Management’s $1B+ stake — is pressuring the board for governance reform. Free cash flow of $1.58B provides a financial cushion, but with the stock down ~42% YTD to $120, the market is pricing in a prolonged recovery. At roughly 10x forward EPS, LULU offers compelling value if margin recovery materializes, but near-term visibility remains limited.
| Scenario | Price Target | Assumptions | Probability |
|---|---|---|---|
| Bull Case | $240 | International momentum accelerates with China comps above 20%. New CEO Heidi O'Neill reinvigorates brand positioning and product innovation. Tariff headwinds ease in H2 2026, enabling gross margin recovery. Chip Wilson proxy fight catalyzes operational improvements. | 20% |
| Base Case | $170 | Revenue lands within FY2026 guidance of $11.35–$11.50B. Gross margin remains pressured at ~54–55% due to tariffs and promotions. Americas comp sales flat to slightly negative. International growth moderates to ~20%. EPS ~$12.20. | 55% |
| Bear Case | $100 | North America deterioration accelerates amid macro slowdown and share loss to Alo Yoga and Vuori. Tariff costs exceed $320M guidance. Inventory markdowns deepen, pushing gross margin below 53%. CEO transition disrupts execution. Proxy contest creates governance instability. | 25% |